Nadia Howlader

Dr. Nadia Howlader has nearly two decades of experience working on clinical studies, cancer epidemiology, and population statistics and modeling. Her research focuses on breast cancer, non-Hodgkin lymphoma, and lung cancer occurrences and outcomes. For about 15 years, Dr. Howlader has been working at the National Cancer Institute (NCI) applying innovative analytic tools and leading congressionally mandated reports on the national cancer burden. She utilizes diverse data systems—including the SEER cancer registries, death certificates, Medicare claims, healthcare provider, and laboratory data—to address high-impact research questions. She also leads NCI efforts to harmonize data systems, create new data elements, and validate these new data sources to enhance SEER registry data. Additionally, as Program Director Dr. Howlader manages NCI grant portfolios in cancer surveillance, health disparities, and biostatistical methods.

Dr. Howlader received her M.S. in Biostatistics from the University of Washington, and her Ph.D. in Epidemiology from the George Washington University. She publishes regularly in highly-ranked journals such as the New England Journal of Medicine, the Journal of the American Medical Association, the Journal of Clinical Oncology, the Journal of the National Cancer Institute, and the American Journal of Epidemiology. She regularly presents to diverse audiences of policymakers, professionals, and academics. Dr. Howlader is a recipient of the 2011 NIH Merit award.